Rain Achieves Unicorn Status with $250M Series C: The Stablecoin Payments Infrastructure Redefining Global Money Movement
Rain has officially joined the unicorn club after raising $250 million in a Series C funding round, pushing its valuation…
UK unicorn Nscale seeks $2B raise just months after record $1.1B Series B
London-based Nscale is once again testing investor appetite, only months after closing one of the largest private funding rounds ever…
Harmattan AI raises $200m Series B at $1.4bn valuation
French defence technology startup Harmattan AI has raised $200 million in a Series B funding round led by aerospace giant…
Cyberette: Building Forensic-Grade Deepfake Detection to Restore Digital Trust
Cyberette is an Amsterdam-based cybersecurity startup founded in 2024 that specialises in forensic-grade deepfake detection and digital identity protection. Founded…
BrightHeart raises €11M to scale AI-powered prenatal ultrasound across the US and Europe
BrightHeart, a medtech company building artificial intelligence software for prenatal ultrasound, has raised €11 million in a Series A funding…
Tucuvi: Building Europe’s First Certified Clinical Voice AI with €17M to Transform Patient Care
What is Tucuvi? Tucuvi is a Madrid-based healthtech company that provides a clinical voice AI platform designed to automate patient…
10 Promising UK Startups to Watch in 2026
Once again, it is that time of the year when we begin our annual series highlighting some of the most…
Top European Tech IPOs 2026: 10 Deeptech Companies to Watch
Europe’s technology sector is moving back towards the public markets. After a quieter period for listings, several well funded deeptech…
Global food security concerns drive €8M raise for London’s AgTech startup Biographica
Biographica secures €8 million to speed up climate-resilient crop development Biographica, a London-based AgTech startup using artificial intelligence to redesign…
Azafaros: Building Hope for Children with Fatal Brain Diseases Through €132M-Funded Innovation
What is Azafaros? Azafaros is a Netherlands-based clinical-stage biotech company founded in 2018 that focuses on developing disease-modifying, oral small…